Neo Ivy Capital Management’s CME Group CME Stock Holding History

Neo Ivy Capital Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$160K	Buy	+760	New	+$162K	0.36%	100
2022 Q4	–	Sell	-1,223	Closed	-$217K	–	367
2022 Q3	$217K	Buy	+1,223	New	+$242K	0.57%	52
2022 Q2	–	Sell	-2,272	Closed	-$540K	–	433
2022 Q1	$540K	Buy	2,272 +541	+31%	+$127K	0.49%	59
2021 Q4	$395K	Sell	1,731 -2,753	-61%	-$606K	0.57%	48
2021 Q3	$729K	Buy	4,484 +4,410	+5,959%	+$893K	0.84%	12
2021 Q2	$16K	Buy	+74	New	+$15.6K	0.02%	378
2021 Q1	–	Sell	-826	Closed	-$150K	–	492
2020 Q4	$150K	Sell	826 -1,234	-60%	-$210K	0.17%	200
2020 Q3	$344K	Sell	2,060 -2,424	-54%	-$408K	0.35%	100
2020 Q2	$729K	Buy	4,484 +4,186	+1,405%	+$750K	0.84%	12
2020 Q1	$52K	Sell	298 -1,267	-81%	-$252K	0.08%	300
2019 Q4	$314K	Buy	+1,565	New	+$321K	0.36%	141
2019 Q3	–	Sell	-5,041	Closed	-$979K	–	304
2019 Q2	$979K	Buy	5,041 +1,878	+59%	+$346K	0.55%	77
2019 Q1	$520K	Buy	+3,163	New	+$559K	0.3%	150

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neo Ivy Capital Management's CME Position: Q4 2023 in Review

Neo Ivy Capital Management opened a new position in CME Group (CME) in Q4 2023: 760 shares worth $160K. The stake represents 0.36% of the portfolio and ranks #100 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in CME as recently as Q3 2022.

Neo Ivy Capital Management first reported a position in CME in Q1 2019 and has held it in 13 quarters since. The position peaked at $979K in Q2 2019. 1,361 funds tracked by Wall St. Rank hold CME as of Q4 2023.

Neo Ivy Capital Management held 760 shares of CME Group worth $160K as of Q4 2023.
CME Group was a new Neo Ivy Capital Management position in Q4 2023.
CME Group made up 0.36% of Neo Ivy Capital Management's portfolio in Q4 2023, its #100 holding.
Neo Ivy Capital Management first reported a position in CME Group in Q1 2019 and has held it in 13 quarters since.
Neo Ivy Capital Management's CME Group position peaked at $979K in Q2 2019.
1,361 funds tracked by Wall St. Rank held CME Group as of Q4 2023.

Based on Neo Ivy Capital Management's 13F filing for Q4 2023, filed 26 Feb 2024.